Tibet Rhodiola Pharmaceutical Holding Co.

SHSE:600211 Stock Report

Market Cap: CN¥10.9b

Tibet Rhodiola Pharmaceutical Holding Future Growth

Future criteria checks 4/6

Tibet Rhodiola Pharmaceutical Holding is forecast to grow earnings and revenue by 21.4% and 19.3% per annum respectively. EPS is expected to grow by 21.5% per annum. Return on equity is forecast to be 29.5% in 3 years.

Key information

21.4%

Earnings growth rate

21.5%

EPS growth rate

Healthcare earnings growth22.2%
Revenue growth rate19.3%
Future return on equity29.5%
Analyst coverage

Low

Last updated19 Aug 2024

Recent future growth updates

No updates

Recent updates

Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt

Sep 02
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt

Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price

Jul 29
Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price

Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital

Jul 12
Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital

Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly

May 21
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly

Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings

May 03
Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings

Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive

Mar 22
Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive

Earnings and Revenue Growth Forecasts

SHSE:600211 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,8281,464N/A1,3731
12/31/20254,0701,215N/A1,1881
12/31/20243,4381,025N/A9081
6/30/20242,9298281,0951,113N/A
3/31/20242,9328111,0981,116N/A
12/31/20233,1348011,0421,063N/A
9/30/20232,9647829681,020N/A
6/30/20233,032703861907N/A
3/31/20232,805498922979N/A
12/31/20222,555370735837N/A
9/30/20222,535233531534N/A
6/30/20222,444173416476N/A
3/31/20222,30022686389N/A
12/31/20212,139209-59367N/A
9/30/20211,94551241551N/A
6/30/20211,782496-3607N/A
3/31/20211,571447117510N/A
12/31/20201,373418207428N/A
9/30/20201,314398205410N/A
6/30/20201,266375244308N/A
3/31/20201,256370449490N/A
12/31/20191,256312441490N/A
9/30/20191,218224328389N/A
6/30/20191,194243488539N/A
3/31/20191,112218337370N/A
12/31/20181,028216266289N/A
9/30/20181,014326334327N/A
6/30/2018933301225215N/A
3/31/2018883244N/A157N/A
12/31/2017916230N/A91N/A
9/30/2017947215N/A251N/A
6/30/2017980195N/A210N/A
3/31/2017946232N/A219N/A
12/31/2016797198N/A250N/A
9/30/2016665145N/A104N/A
6/30/2016720129N/A158N/A
3/31/20161,013103N/A190N/A
12/31/20151,38392N/A134N/A
9/30/20151,67854N/A87N/A
6/30/20151,82025N/A27N/A
3/31/20151,76221N/A-47N/A
12/31/20141,66821N/A-141N/A
9/30/20141,64744N/A91N/A
6/30/20141,54738N/A112N/A
3/31/20141,46532N/A186N/A
12/31/20131,40227N/A279N/A
9/30/20131,26920N/A48N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600211's forecast earnings growth (21.4% per year) is above the savings rate (2.9%).

Earnings vs Market: 600211's earnings (21.4% per year) are forecast to grow slower than the CN market (23.1% per year).

High Growth Earnings: 600211's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600211's revenue (19.3% per year) is forecast to grow faster than the CN market (13.3% per year).

High Growth Revenue: 600211's revenue (19.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 600211's Return on Equity is forecast to be high in 3 years time (29.5%)


Discover growth companies